Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer
Kathleen M. McAndrews, Fei Xiao, Antonios Chronopoulos, et al.
Life Science Alliance (2021) Vol. 4, Iss. 9, pp. e202000875-e202000875
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

KRAS mutation: from undruggable to druggable in cancer
Lamei Huang, Zhixing Guo, Fang Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 593
The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 284
Exosome engineering in cell therapy and drug delivery
Somayeh Sadeghi, Fahimeh Ramezani Tehrani, Safa Tahmasebi, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 145-169
Open Access | Times Cited: 159
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144
Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment
Yujie Liang, Xiao Xu, Limei Xu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4866-4878
Open Access | Times Cited: 116
Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives
Srijita Sen, Joyal Xavier, Nitesh Kumar, et al.
3 Biotech (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 80
Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications
Liwei Wang, Di Wang, Zhaoming Ye, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 59
Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
Wanzun Lin, Li Chen, Haojiong Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 40
Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Maryam Taghdiri, Claudio Mussolino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7333-7333
Open Access | Times Cited: 18
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1435-1435
Open Access | Times Cited: 63
Cell-derived extracellular vesicles for CRISPR/Cas9 delivery: engineering strategies for cargo packaging and loading
Yujie Liang, Zoya Iqbal, Jianhong Wang, et al.
Biomaterials Science (2022) Vol. 10, Iss. 15, pp. 4095-4106
Closed Access | Times Cited: 49
CRISPR/Cas systems: Delivery and application in gene therapy
Jie Huang, Yitong Zhou, Jie Li, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 49
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum, Juan L. Vivero‐Escoto
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114357-114357
Open Access | Times Cited: 40
Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 39
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 34
Advances in development of exosomes for ophthalmic therapeutics
Ying Tian, Tao Zhang, Jing Li, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114899-114899
Closed Access | Times Cited: 31
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 30
KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Yunkai Yang, Huan Zhang, Shanshan Huang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 709-709
Open Access | Times Cited: 27
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Xinglong Zhu, Mengyu Gao, Yongfeng Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 26
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
Yaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102040-102040
Open Access | Times Cited: 26
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
Vivek P. Chavda, Vrashabh V. Sugandhi, Chandrakantsing V. Pardeshi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 85, pp. 104579-104579
Open Access | Times Cited: 23
Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
Fusion of Exosomes and Nanotechnology: Cutting-Edge Cancer Theranostics
R. Agnihotram, Rajib Dhar, Debolina Dhar, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 8489-8506
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top